CIPO Patents = 2

EPO Patents = 1

Forward Citations = 0

Loading Chart...

7 inventors (with patents filed for the assignee):

Richard B Silverman (4 out of 107 patents)

Donald R Kirsch (4 out of 5 patents)

Radhia Benmohamed (4 out of 5 patents)

4. Anthony C Arvanites (4 out of 5 patents)

5. Richard I Morimoto (4 out of 7 patents)

6. Wei Zhang (3 out of 4 patents)

7. Tian Chen (1 out of 1 patent)

8. Guoyao Xia (1 patent)

9. Tian Chen (0 patent)

4 patents: Sort by Forward Citations

1. 10167263 - Treatment of amyotrophic lateral sclerosis (2019-01-01),

2. 9593069 - Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis (2017-03-14),

3. 9162968 - Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis (2015-10-20),

4. 8722939 - Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis (2014-05-13),

Cambria Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on researching and developing innovative therapies for serious and life-threatening medical conditions. With a strong commitment to improving patient outcomes, Cambria leverages cutting-edge technologies and groundbreaking research to deliver safe and effective treatments to those in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

4 Patents

#378 in Cambridge, MA

#3,235 in Massachusetts

#58,991 in US

Cambridge, MA, United States of America

Cambria Pharmaceuticals, Inc.

Forward Citations = 0

7 inventors:

Richard B Silverman (4 out of 107 patents)

Donald R Kirsch (4 out of 5 patents)

Radhia Benmohamed (4 out of 5 patents)

4. Anthony C Arvanites (4 out of 5 patents)

5. Richard I Morimoto (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com